China, Sept. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The clinical study on the efficacy and safety of Crisugabalin in treating chemotherapy-induced peripheral neuropathy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133212
Registration Time: 2026/09/23
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital of Soochow University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335809
Published by HT Digital Content Services with permission from Health Daily Digest....